이효진 (충남대학교 의과대학, 충남대학교병원)님 | 한빛사연구자 > 한빛사

충남대학교 의과대학, 충남대학교병원

CV File

최종업데이트 2025.09.02.

[Correspondence] Engineered Salmonella delivering the NMDAR antagonist conantokin G synergizes with PD-L1 blockade to enhance colorectal cancer regression
- Exp. Hematol. Oncol., 15 June 2026 | https://doi.org/10.1186/s40164-026-00794-0
- 2026-06
- 의약학
- 한빛사논문
Attenuated Salmonella secreting interleukin-21 activates T-cells and induces anti-tumor effects
- Acta Pharm. Sin. B, Available online 17 September 2025 | https://doi.org/10.1016/j.apsb.2025.09.025
- 2025-09
- 의약학
- 한빛사논문
Tumour-specific delivery of ω-conotoxin MVIIA via engineered Salmonella for safe anticancer therapy
- J. Adv. Res., Aug 30 2025, S2090-1232(25)00675-7 | https://doi.org/10.1016/j.jare.2025.08.060
- 2025-08
- 의약학
- 한빛사논문
Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer
- Int. J. Oncol, Feb 2009, 34 (2) | https://doi.org/10.3892/ijo_00000172
- 2009-02
- 의약학
- 상위피인용논문
Engineering Bacterial Secretion Systems for Enhanced Tumor Imaging and Surgical Guidance
- Adv. Mater., May 21 2025, | https://doi.org/10.1002/adma.202504389
- 2025-05
- 의약학
- 한빛사논문
Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF
- Acta Pharm. Sin. B, Available online 10 July 2024 | https://doi.org/10.1016/j.apsb.2024.07.011
- 2024-07
- 의약학
- 한빛사논문
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)
- J. Immunother. Cancer, Mar 13 2024, 12 (3) e008638 | https://doi.org/10.1136/jitc-2023-008638
- 2024-03
- 생명과학
- 한빛사논문
[Correspondence] Enfortumab Vedotin in Advanced Urothelial Carcinoma
- N. Engl. J. Med., July 1, 2021, 385:93-94 | DOI: 10.1056/NEJMc2106975
- 2021-07
- 의약학
- 한빛사논문
- 이효진(충남대학교병원)
[Images in Clinical Medicine]A Smooth, Shiny Tongue
- N. Engl. J. Med., February 5, 2009, 360:e8 | DOI: 10.1056/NEJMicm075733
- 2009-03
- 의약학
- 한빛사논문
[Correspondence]Nivolumab and ipilimumab in advanced melanoma
- N. Engl. J. Med., December 21, 2017, 377:2503-2504 | DOI: 10.1056/NEJMc1714339
- 2017-12
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기